The PhD programme will train researchers of high ranking expertise and with a strong background, in the areas of biotechnology and of biocomputational, pharmaceutical and pharmacological studies.
PhD candidates will be trained in the following areas :
PhD candidates should become capable to carry out autonomously a scientific research. One of the major goals is to promote the enrollment of PhDs in companies interested in highly qualified experts in the described fields.
PhDs will be also capable to work in the field of higher education.
The Doctoral programme develops research themes related to the discovery of new therapeutic targets as well as of new drugs with improved efficacy and safety.
The discovery of novel drug targets contributing to a specific disease and / or its progression, in fact, is usually followed by the creation of new drugs (small molecules or biologics) up to the development of the medicinal product.
An integrated cross training, which spans all the drug development pipeline, is proposed to the PhD candidate. This will be instrumental for their future employment in pharmaceutical and biotechnology companies.
The themes of the new PhD programme are mainly focused on :
Skills / Qualifications
Applicants, regardless of age and citizenship status, can apply for the admission to the selection procedure if they have awarded at least one of the following degrees :
Applicants who are yet to obtain their Second Cycle Degree are admitted to the selection procedure on condition that they obtain their degree by no later than October, 31st 2021.
Other required documents :
More information in the PhD Programme Table.